Development and validation of risk-stratified biopsy decision pathways incorporating MRI and PSA-derived indicators.

Distribution of PCa within PSAD and f/tPSA risk intervals The proportions of PCa and csPCa in low, intermediate-low, intermediate-high, and high intervals of PSAD showed an increasing trend ( Table 3 , Figure 2 ), with 62% (331/531) of PCa and 56% (298/531) of csPCa in the high interval.

also in 63,971 other papers

The proportions of PCa and csPCa in extremely low, low, intermediate-low, and normal intervals of f/tPSA showed a decreasing trend ( Table 4 , Figure 2 ), with 64.0% (174/272) of PCa and 58% (159/272) of csPCa in the high interval.

also in 47,180 other papers